US FDA grants six month ‘grace period’ for MoCRA facility registration and product listing

By Julia Wray | Published: 9-Nov-2023

The Modernization of Cosmetics Regulation Act is the first major update to the FDA’s authority over cosmetic products since the 1930s

You need to be a subscriber to read this article.
Click here to find out more.

The US Food and Drug Administration (FDA) is deferring enforcement for upcoming facility registration and product listing by six months. 

New guidance follows an announcement by the FDA earlier this month that more information about the launch date for electronic and paper submission forms would be shared in coming weeks.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like